Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

Market Cap	11.25B +42.1%
Revenue (ttm)	1.86B -4.1%
Net Income	-334.96M
EPS	-0.21
Shares Out	1.58B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,344,224
Average Volume	29,118,854
Open	7.14
Previous Close	7.02
Day's Range	6.81 - 7.21
52-Week Range	4.26 - 9.09
Beta	0.62
RSI	47.37
Earnings Date	Apr 29, 2026

About SHE:002099

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, and other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 2,611
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002099

Financial Performance

In 2024, SHE:002099's revenue was 1.94 billion, a decrease of -10.75% compared to the previous year's 2.17 billion. Losses were -330.27 million, -21.38% less than in 2023.